Fig. 4From: A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigsNanoS100-SwIAV altered the frequencies of T-lymphocytes in TBLN MNCs and BAL cells of vaccinated pigs. Five-week-old SPF pigs were administered twice ID/IM with NanoS100-SwIAV, Nano11-SwIAV or control NanoS100 and challenged at post-prime vaccination day 35 with SwIAV H1N1-OH7. TBLN MNCs and BAL cells were isolated at DPC6 and were restimulated with SwIAV H1N1-OH7 in vitro. The cells were labeled and analyzed by flow cytometry for the frequencies of T-lymphocyte subsets: A Total IL-17A+ CTLs-IM [CD3+CD4−CD8α+CD8β+IL-17A+]; B IL-17A+ Late effector CTLs-IM [CD3+CD4−CD8α+CD8β+CD27−IL-17A+]; C Total IFNγ+ CTLs-IM [CD3+CD4−CD8α+CD8β+IFNγ+]; D IFNγ+ Early effector CTLs-IM [CD3+CD4−CD8α+CD8β+CD27+IFNγ+]; E IFNγ+ Late effector CTLs-IM [CD3+CD4−CD8α+CD8β+CD27−IFNγ+] in TBLN MNCs; F Total CTLs-ID [CD3+CD4−CD8α+CD8β+]; G Early effector CTLs-ID [CD3+CD4−CD8α+CD8β+CD27+]; H Central memory T-helper/memory cells-IM [CD3+CD4+CD8α+CD8β−CD27+] in BAL cells. Data represent the mean value of 7–8 pigs ± SEM. Statistical analysis was performed by one-way ANOVA followed by Tukey’s post-test. For head-to-head comparison between two groups, Unpaired t-test was used. Asterisk/Pound represents significant difference between indicated groups (*/♯ p < 0.05, **/♯♯ p< 0.01, and ***/♯♯♯ p < 0.001)Back to article page